Grant: Engage Grants Program
University of British Columbia
$25,000.00
Endovascular simulator for aortic aneurysms
FY 2017-18
Summary
Cardiovascular disease is the leading cause of death in the world. According to the American HeartAssociation, more than 85 million Americans suffer from cardiovascular disease with the total treatmentspending exceeding $320B in 2011 and expected to reach $1,208B in 2030. Aortic pathologies such asdissection and aneurysm represent a particularly emergent class of cardiovascular diseases. Open surgicalprocedure is the current gold standard for treating thoracic aortic dissection. However, the stent graftimplantation is one of the potential alternatives for treating patients at high risk for an open surgical procedure.Various hemodynamic parameters are suspected to be major mechanical factors related to the genesis andaneurysm growth.Vivitro Labs Inc. is an industry-leading cardiovascular test equipment and related laboratory testing company.Services include the assessment of hydrodynamic performance of cardio devices which are used for submissionwith regulatory bodies such as the FDA. ViVitro's pulse duplicator is the most widely used heart simulator inthe world. The company's problem is to broaden the suitability of the heart simulator to simulate a descendingaortic aneurysm before and after treatment by the stent graft implantation. The objective of this study is toinvestigate the suitability of the ViVitro's simulator for aortic aneurysm before and after stent graftimplantation.
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
518167-2017
Name nom
Green, Sheldon
Department département
Mechanical Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Endovascular simulator for aortic aneurysms
Keyword
NSERC
Application summary
Cardiovascular disease is the leading cause of death in the world. According to the American HeartAssociation, more than 85 million Americans suffer from cardiovascular disease with the total treatmentspending exceeding $320B in 2011 and expected to reach $1,208B in 2030. Aortic pathologies such asdissection and aneurysm represent a particularly emergent class of cardiovascular diseases. Open surgicalprocedure is the current gold standard for treating thoracic aortic dissection. However, the stent graftimplantation is one of the potential alternatives for treating patients at high risk for an open surgical procedure.Various hemodynamic parameters are suspected to be major mechanical factors related to the genesis andaneurysm growth.Vivitro Labs Inc. is an industry-leading cardiovascular test equipment and related laboratory testing company.Services include the assessment of hydrodynamic performance of cardio devices which are used for submissionwith regulatory bodies such as the FDA. ViVitro's pulse duplicator is the most widely used heart simulator inthe world. The company's problem is to broaden the suitability of the heart simulator to simulate a descendingaortic aneurysm before and after treatment by the stent graft implantation. The objective of this study is toinvestigate the suitability of the ViVitro's simulator for aortic aneurysm before and after stent graftimplantation.